1984
DOI: 10.1073/pnas.81.10.3190
|View full text |Cite
|
Sign up to set email alerts
|

Potential use of biaromatic L-phenylalanyl derivatives as therapeutic agents in the treatment of sickle cell disease.

Abstract: N-Phenylacetyl-L-phenylalanine (PAP) and L-phenylalanyl-3-aminopyridine (PAPA) are biaromatic agents with properties that make them suitable candidates for the development of a useful therapeutic agent for the treatment-of sickle cell disease. PAP and PAPA are taken up by the erythrocyte to give intra-/extracellular concentration ratios of 2.2 and 1.5, respectively, after a 2-hr exposure period. The intracellular buildup of PAP and PAPA produces moderate decreases in the mean corpuscular hemoglobin concentrati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

1985
1985
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(10 citation statements)
references
References 21 publications
0
10
0
Order By: Relevance
“…FOB functions as an antisickling agent by causing the erythrocyte to take up water after the bisphenyl compound has traversed the red cell membrane (Votano et al, 1984).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…FOB functions as an antisickling agent by causing the erythrocyte to take up water after the bisphenyl compound has traversed the red cell membrane (Votano et al, 1984).…”
Section: Resultsmentioning
confidence: 99%
“…The antigelling agents L-lysyl-Lphenylalanyl-L-phenylalanine (KFF) and L-phenylalanylglycylglycyl-D-phenylalanine (FGGF) were synthesized as described previously (Gorecki et al, 1980a). The antisickling agents L-phenylalanine benzyl ester (FOB) and A-phenylacetyl-L-phenylalanine (PAF) were also synthesized as previously described (Gorecki et al, 1980b;Votano et al, 1984). Single-Crystal X-ray Structure Determination.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…This anti-sickling activity of the Phe could be explained by studies which have shown that AA and in particular aromatic AA have the possibility of inhibiting the gelling of deoxyhemoglobin S and partially preventing the formation of sickle cells (Noguchi, 1977;Noguchi andAckeman, 1983). The Phe esters and Phe-containing peptides have the same property (Acquaye and al., 1982;Votano and al., 1984).…”
Section: Test With the Macerationmentioning
confidence: 99%
“…Chemical compounds that inhibit this process are potential candidates for use as therapeutic agents. Among many compounds studied that delay the onset of polymer formation through non-covalent interactions [1][2][3][4][5][6][7][8][9], tryptophan and 5bromotryptophan (5-BrTrp), as well as the corresponding dipeptides, have been found to be among the more potent polymerization inhibitors, and the potency of the dipeptide of 5-BrTrp is on the threshold of being clinically useful [5,9]. Although the binding sites were determined crystallographically for one of the dipeptides, namely succinyl-Trp-Trp (STT) [10], the binding sites of the building blocks of these dipeptides, namely tryptophan and 5-BrTrp, have only been suggested, but not fully established, by the use of spin-labelled derivatives and computer modelling [11,12] (C. J. Yuan, L. Kar, P. Z. deCroos, B. L. Currie and M. E. Johnson, unpublished results).…”
Section: Introductionmentioning
confidence: 99%